Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pegvaliase

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioMarin's Biologic Palynziq (pegvaliase) Receives Approval in the U.S.
    BioMarin's Biologic Palynziq (pegvaliase) Receives Approval in the U.S.

    09 Dec 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    09 Dec 2023
    Share Share
    Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US
    Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US

    25 Nov 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    25 Nov 2020
    Share Share
    Biomarin Pharm's Biological Pegvaliase-Pqpz Receives Approval In US
    Biomarin Pharm's Biological Pegvaliase-Pqpz Receives Approval In US

    08 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    08 Oct 2020
    Share Share
    BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion
    BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion

    07 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biomarin-pioneer-in-rare-disease-treatments-for-phenylketonuria-pku-receives-fda-approval-of-label-expansion-to-allow-maximum-dose-of-60-mg-for-palynziq-pegvaliase-pqpz-injection-for-treatment-of-adults-with-pku-301147358.html

    PRNEWSWIRE
    07 Oct 2020
    Share Share
    EU nod for BioMarin’s second PKU therapy Palynziq
    EU nod for BioMarin’s second PKU therapy Palynziq

    07 May 2019

    // Andrew McConaghie PMLIVE

    http://www.pmlive.com/pharma_news/eu_nod_for_biomarins_second_pku_therapy_palynziq_1286947

    Andrew McConaghie PMLIVE
    07 May 2019
    Share Share
    Dupixent® (dupilumab) Approved for Severe Asthma by European Commission
    Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

    07 May 2019

    // PRESS RELEASE

    http://www.news.sanofi.us/2019-05-07-Dupixent-R-dupilumab-Approved-for-Severe-Asthma-by-European-Commission

    PRESS RELEASE
    07 May 2019
    Share Share